Literature DB >> 23876646

RETIRED: Technical update on pessary use.

Magali Robert1, Jane A Schulz2, Marie-Andrée Harvey3.   

Abstract

This document has been archived because it contains outdated information. It should not be consulted for clinical use, but for historical research only. Please visit the journal website for the most recent guidelines.

Entities:  

Keywords:  complications; fitting; incontinence; pessary; prolapse

Mesh：

Year:  2013        PMID： 23876646     DOI： 10.1016/S1701-2163(15)30888-4

Source DB:  PubMed          Journal:  J Obstet Gynaecol Can        ISSN： 1701-2163


  11 in total

Review 1.  An integrative review and severity classification of complications related to pessary use in the treatment of female pelvic organ prolapse.

Authors:  Marwa Abdulaziz; Lynn Stothers; Darren Lazare; Andrew Macnab
Journal:  Can Urol Assoc J       Date:  2015 May-Jun       Impact factor: 1.862

2.  The effect of hydroxyquinoline-based gel on pessary-associated bacterial vaginosis: a multicenter randomized controlled trial.

Authors:  Kate V Meriwether; Rebecca G Rogers; Ellen Craig; Sean D Peterson; Robert E Gutman; Cheryl B Iglesia
Journal:  Am J Obstet Gynecol       Date:  2015-04-30       Impact factor: 8.661

Review 3.  Rare complications of pessary use: A systematic review of case reports.

Authors:  Stefan Dabic; Christina Sze; Stephanie Sansone; Bilal Chughtai
Journal:  BJUI Compass       Date:  2022-07-05

4.  Pessary types and discontinuation rates in patients with advanced pelvic organ prolapse.

Authors:  Birte Wolff; Kathryn Williams; Allen Winkler; Lawrence Lind; Dara Shalom
Journal:  Int Urogynecol J       Date:  2016-12-10       Impact factor: 2.894

Review 5.  Female pelvic organ prolapse using pessaries: systematic review.

Authors:  Suelene Costa de Albuquerque Coelho; Edilson Benedito de Castro; Cássia Raquel Teatin Juliato
Journal:  Int Urogynecol J       Date:  2016-03-18       Impact factor: 2.894

6.  Defecatory dysfunction and other clinical variables are predictors of pessary discontinuation.

Authors:  Erin G Dengler; Louisa A Mounsey; Francesca Gines; Manahil Agha; Terri Long; Elizabeth J Geller
Journal:  Int Urogynecol J       Date:  2018-10-20       Impact factor: 2.894

7.  Documenting pessary offer prior to hysterectomy for management of pelvic organ prolapse.

Authors:  Anne G Sammarco; Daniel M Morgan; Neil S Kamdar; Carolyn W Swenson
Journal:  Int Urogynecol J       Date:  2018-06-22       Impact factor: 2.894

8.  A nationwide survey concerning practices in pessary use for pelvic organ prolapse in The Netherlands: identifying needs for further research.

Authors:  Joost Velzel; Jan Paul Roovers; C H Van der Vaart; Bart Broekman; Astrid Vollebregt; Robert Hakvoort
Journal:  Int Urogynecol J       Date:  2015-06-11       Impact factor: 2.894

Review 9.  Pessary use in stress urinary incontinence: a review of advantages, complications, patient satisfaction, and quality of life.

Authors:  Ghadeer Al-Shaikh; Sadiqa Syed; Somaia Osman; Abdulrahman Bogis; Ahmed Al-Badr
Journal:  Int J Womens Health       Date:  2018-04-17

10.  Pessaries and rectovaginal fistulae: consequences of delayed clinical follow-up in the Covid-19 pandemic.

Authors:  Jordan Mendelson; Bogdan Grigorescu; Catherine Quinn; George Lazarou
Journal:  Int Urogynecol J       Date:  2021-07-08       Impact factor: 2.894
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.